← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Valitor, Inc.
Berkeley, CA
$3,772,284
Total funding
9
Grants
Funding over time
peak $782.9K · FY2012–21$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$3,772,284 · 9
By mechanism
R43$2,272,628 · 8
R44$1,499,656 · 1
Investigators at Valitor, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Multivalent Conjugates of Sonic Hedgehog to Accelerate Diabetic Wound Healing$782,937
R44 · FY2015 · AR
Multivalent Conjugates of Sonic Hedgehog to Accelerate Diabetic Wound Healing$716,719
R44 · FY2014 · AR
Multivalent Conjugates of Sonic Hedgehog to Accelerate Diabetic Wound Healing$311,158
R43 · FY2012 · AR
Multivalent Growth Factor Conjugates to Accelerate Wound Neovascularization in El$310,870
R43 · FY2013 · GM
Antibody-hyaluronic acid bioconjugates for localized treatment of chronic non-infectious uveitis$299,284
R43 · FY2021 · EY
Bifunctional Protein-Polymer Bioconjugates for Localized Melanoma Immunotherapy$298,864
R43 · FY2018 · CA
Multivalent Anti-VEGF Conjugates for Sustained Treatment of Diabetic Retinopathy$285,965
R43 · FY2016 · EY
Multivalent protein-polymer conjugates to improve growth factor stability and therapeutic efficacy for wound healing$284,580
R43 · FY2016 · GM
Long-acting anti-TNFα conjugates to minimize osteolysis around joint replacement devices$224,934
R43 · FY2017 · AR
Anti-inflammatory bioconjugates for sustained inhibition of post-traumatic osteoarthritis following joint injury$224,838
R43 · FY2018 · AR
Multivalent Anti-VEGF Conjugates for Sustained Treatment of Diabetic Retinopathy$32,135
R43 · FY2017 · EY